The Effect of Interferon-α on Beta-1 Integrin Mediated Adhesion and Growth Regulation in Chronic Myelogenous Leukemia

References

• Rowley J. D. A new consistent chromosome abnormality in chronic myelogenous leukemia. Nature (Lond.) 1973; 243: 209
   Web of Science ®Google Scholar
• DeKlein A., Van Kessel A. G., Grosveld G., Bartram C. R., Hagemeijer A., Bostooma D., Spurr N. K., Heisterkamp N., Groffen J., Stephenson J. R. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukemia. Nature (Lond.) 1982; 300: 765
   PubMed Web of Science ®Google Scholar
• Daley G. O., Baltimore D. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic leukemia-specific P210 bcr/abl protein. Proc Natl Acad Sci USA 1988; 85: 9312–9316
   PubMed Web of Science ®Google Scholar
• Daley G. Q., Van Etten R. A., Baltimore D. Induction of chronic myelogenous leukemia in mice by the p210 bcr/abl gene of the Philadelphia chromosome. Science 1990; 247: 824–247
   PubMed Web of Science ®Google Scholar
• Talpaz M., Kantarjian H. M., Kurzrock R., Trujillo J. M., Gutterman J. U. Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia Philadelphia chromosome positive patients. Ann. Intern. Med 1991; 114: 532–538
   PubMed Web of Science ®Google Scholar
• Kantarjian H. M., O'Brien S., Anderlini P., Talpaz M. Treatment of chronic myelogenous leukemia: current status and investigational options. Blood 1996; 87: 3069–3081
   PubMed Web of Science ®Google Scholar
• Kantarjian H. M., Smith T. L., O'Brien S., Beran M., Pierce S., Talpaz M. Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-α therapy. Ann Intern Med 1995; 122: 254–261
   PubMed Web of Science ®Google Scholar
• Dhingra K., Kurzrock R., Baine R., Eastman S., Kantarjian H., Gutterman J. U., Talpaz M. Minimal residual disease in interferon-treated chronic myelogenous leukemia: Results and pitfalls of analysis based on polymerase chain reaction. Leukemia 1992; 6: 754
   PubMed Web of Science ®Google Scholar
• Talpaz M., Estrov Z., Kantarjian H., Ku S., Foteh A., Kurzrock R. Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. J Clin Invest 1994; 94: 1383–1389
   PubMed Web of Science ®Google Scholar
• Cashman J., Eaves A. C., Eaves C. J. Regulated proliferation of primitive hematopoietic progenitors in long-term human marrow cultures. Blood 1985; 66: 1002–1005
   PubMed Web of Science ®Google Scholar
• Eaves A. C., Cashman J. D., Gaboury L. A., Kalousek D. K., Eaves C. J. Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells. Proc Natl Acad Sci USA 1986; 83: 5306–5310
   PubMed Web of Science ®Google Scholar
• Dexter T. M., Coutinho L. H., Spooncer E., Heyworth C. M., Daniel C. P., Schiro R., Chang J., Allen T. D. Stromal cells in haemopoiesis. Molecular Control of Haemopoiesis 1990; 76–95
   Google Scholar
• Zuckerman K. S., Wicha M. S. Extracellular matrix production by the adherent cells in long-term murine marrow cultures. Blood 1983; 61: 540–556
   PubMed Web of Science ®Google Scholar
• Verfaillie C. M. Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long term in vitro hematopoiesis. Blood 1992; 79: 2821–2826
   PubMed Web of Science ®Google Scholar
• Cashman J. D., Eaves A. C., Raines E. W., Ross R., Eaves C. J. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-p. Blood 1990; 75: 96–101
   PubMed Web of Science ®Google Scholar
• Roberts R., Gallagher J., Spooncer E., Allen T. D., Bloomfield F., Dexter T. M. Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature 1988; 332: 376–378
   PubMed Web of Science ®Google Scholar
• Hurley R. W., McCarthy J. B., Verfaillie C. M. Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. J Clin Invest 1995; 96: 511–519
   PubMed Web of Science ®Google Scholar
• Hynes R. O. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11–25
   PubMed Web of Science ®Google Scholar
• Davis L. S., Oppenheimer-Marks N., Bednarczyk J. L., McIntyre B. W., Lipsky P. E. Fibronectin promotes proliferation of naive and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules. J Immunol 1990; 145: 785–793
   PubMed Web of Science ®Google Scholar
• Meredith J., Jr., Takada Y., Fomaro M., Languino L. R., Schwartz M. A. Inhibition of cell cycle progression by the alternatively spliced integrin β1c. Science 1995; 269: 1570–1572
   PubMed Web of Science ®Google Scholar
• Adams J. C., Watt F. M. Fibronectin inhibits the terminal differentiation of human keratinocytes. Nature (Lond.) 1989; 340: 307–309
   PubMed Web of Science ®Google Scholar
• Zhang Z., Vuori K., Reed J. C., Ruoslahti E. The α5β1 integrin supports survival of cells on fibronectin and upregulates Bcl-2 expression. Proc Natl Acad Sci USA 1995; 92: 6161–6165
   PubMed Web of Science ®Google Scholar
• Clark E. A., Brugge J. S. Integrins and signal transduction pathways: the road taken. Science 1995; 268: 233–239
   PubMed Web of Science ®Google Scholar
• Miyake K., Weissman I. L., Greenberger J. S., Kincade P. W. Evidence for a Role of the Integrin VLA-4 in Lympho-hemopoeisis. J Exp Med 1991; 173: 599–607
   PubMed Web of Science ®Google Scholar
• Teixido J., Hemler M. E., Greenberger J. S., Anklesaria P. Role of β1 and β2 Integrins in the Adhesion of Human CD34hi Stem Cells to Bone Marrow Stroma. J Clin Invest 1992; 90: 358–367
   PubMed Web of Science ®Google Scholar
• Vuillet-Gaugler M. H., Breton-Gorius J., Vainchenker W., Columbel L. Loss of attachment to fibronectin with terminal human erythroid differentiation. Blood 1990; 75: 865–873
   PubMed Web of Science ®Google Scholar
• Verfaillie C. M., McCarthy J. B., McGlave P. B. Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their adhesion to fibronectin. J Exp Med 1991; 174: 693–703
   PubMed Web of Science ®Google Scholar
• Simmons P. J., Masinovsky B., Longenecker B. M., Berenson R., Torok-Storb B., Galatin W. M. Vascular cell adhesion molecule 1 is expressed by bone marrow stromal cells and mediates binding of hematopoietic cells. Blood 1992; 80: 388–395
   PubMed Web of Science ®Google Scholar
• Hurley R. W., McCarthy J. B., Wayner E. A., Verfaillie C. M. Monoclonal antibody induced clustering of the alpha-4 integrin inhibits hematopoietic progenitor proliferation. Exp Hematol 1994; 22: 335, (Abstr.)
   Google Scholar
• Gordon M. Y., Dowding C. R., Riley G. P., Goldman J. M., Greaves M. F. Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature 1987; 328: 342–344
   PubMed Web of Science ®Google Scholar
• Gordon M. Y., Atkinson J., Clarke D., Dowding C. R., Goldman J. M., Grimsley P. G., Siczkowski M., Greaves M. F. Deficiency of a phosphatidylinositol-anchored cell adhesion molecule influences haematopoietic progenitor binding to marrow stroma in chronic myeloid leukemia. 1991; 5: 693–698
   Google Scholar
• Upadhyaya G., Guba S. C., Sih S. A., Feinberg A. P., Talpaz M., Kantarjian H. M., Deisseroth A. B., Emerson S. G. Interferon-alpha restores the deficient expression of the cytoadhesion molecule Lymphocyte Function Antigen-3 by chronic myelogenous leukemia progenitor cells. J Clin Invest 1991; 88: 2131–2136
   PubMed Web of Science ®Google Scholar
• Verfaillie C. M., McCarthy J. B., McGlave P. B. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia: decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. J Clin Invest 1992; 90: 1232–1239
   PubMed Web of Science ®Google Scholar
• Lundell B. I., McCarthy J. B., Kovach N. L., Verfaillie C. M. Activation independent a5pl integrin-mediated adhesion to fibronectin decreases proliferation of chronic myelogenous leukemia progenitors and K562 cells. Blood 1996; 87: 2450–2458
   PubMed Web of Science ®Google Scholar
• Bhatia R., McGlave P. B., Dewald G. W., Blazar B. R., Verfaillie C. M. Abnormal Function of the Bone Marrow Microenvironment in Chronic Myelogenous Leukemia: Role of Malignant Stromal Macrophages. Blood 1995; 85(12)3636–3645
   PubMed Web of Science ®Google Scholar
• Otsuka T., Eaves C. J., Humphries R. K., Hogge D. E., Eaves A. C. Lack of evidence for abnormal autocrine or paracrine mechanisms underlying the uncontrolled proliferation of primitive chronic myeloid leukemia progenitor cells. Leukemia 1991; 5: 861–868
   PubMed Web of Science ®Google Scholar
• Dowding C., Guo A.-P., Maisin D., Gordon M. Y., Goldman J. M. The effects of interferon-ot on the proliferation of CML progenitor cells are not related to the precise position of the M-BCR breakpoint. Br J Hematol 1991; 77: 165–171
   PubMed Web of Science ®Google Scholar
• Dowding C., Guo A.-P., Osterholz J., Sickowski M., Goldman J., Gordon M. Interferon-α overrides the deficient adhesion of chronic myelogenous leukemia primitive progenitor cells to bone marrow stromal cells. Blood 1991; 78: 499–505
   PubMed Web of Science ®Google Scholar
• Bhatia R., Wayner E. A., McGlave P. B., Verfaillie C. M. Interferon-α restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired pi integrin receptor function. J Clin Invest 1994; 94: 384–391
   PubMed Web of Science ®Google Scholar
• Bhatia R., McCarthy J. B., Verfaillie C. M. Interferon-α restores normal normal β1 integrin mediated inhibition hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia. Blood 1996; 87: 3883
   PubMed Web of Science ®Google Scholar
• Bhatia R., McGlave P. B., Verfaillie C. M. Treatment of marrow stroma with interferon-α restores normal β1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. J Clin Invest 1995; 96: 931–939
   PubMed Web of Science ®Google Scholar
• Tanaka Y., Adams D. H., Hubscher S., Hirano H., Siebenlist U., Shaw S. T cell adhesion induced by proteoglycan immobilized cytokine MIP-1β. Nature (Land.) 1993; 361: 79–82
   PubMed Web of Science ®Google Scholar
• Luna E. J., Hitt A. L. Cytoskeleton-plasma membrane interactions. Science 1992; 258: 955–964
   PubMed Web of Science ®Google Scholar
• Burridge K., Fath K., Kelley T., Nuckolls G., Turner C. Focal adhesions: transmembrane junctions between the extracellular matrix and the cytoskeleton. Ann Rev Cell Biol 1988; 4: 487–525
   PubMedGoogle Scholar
• Schlaepfer D. D., Hanks S. K., Hunter T., van der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 1994; 372: 786–791
   PubMed Web of Science ®Google Scholar
• Guinebault C., Payrastre B., Racaud-Sultan C., Mazarguil H., Breton M., Mauco G., Plantavid M., Chap H. Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85a with actin filaments and focal adhesion kinase. J Cell Biol 1995; 129: 831–842
   PubMed Web of Science ®Google Scholar
• Bhatia R., Munthe H., Verfaillie C. Decreased bl integrin receptor capping in CML progenitors, reflecting abnormal receptor cytoskeleton interactions, is normalized by interferon-a. Blood, 88(suppl. 1)637A
   Google Scholar
• Wetzler M., Talpaz M., van Etten R. A., Hirsh-Ginsberg C., Beran M., Kurzrock R. Subcellular localization of Bcr, Abl and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. J Clin Invest 1993; 92: 1925–1939
   PubMed Web of Science ®Google Scholar
• McWhirter J. R., Wang J. Y. J. An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J 1993; 12: 1533–1546
   PubMed Web of Science ®Google Scholar
• Salgia R., Li J.-L., Lo S. H., Brunkhorst B., Kansas G. S., Sobhany E. S., Sun Y., Pisick E., Hallek M., Ernst T., Tantravahi R., Chen L. B., Griffin J. D. Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL. J Biol Chem 1995; 270: 5039–5047
   PubMed Web of Science ®Google Scholar
• Salgia R., et al. Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing P210BCR/ABL. Oncogene 1995; 11: 1149–1155
   PubMed Web of Science ®Google Scholar
• Gotoh A., Miyazawa K., Ohyashiki K., Tauchi T., Boswell H. S., Broxmeyer H. E., Toyama K. Tyrosine Phosphorylation and Kinase Activation of Focal Adhesion Kinase (pl25FAK) in Human Ph-Positive leukemia Cell Lines. Blood 1993; 82(10)104a, Suppl. 1
   Web of Science ®Google Scholar
• Oda T., Heaney C., Hagopian J. R., Okuda K., Griffin J. D., Druker B. J. Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia. J Biol Chem 1994; 269(37)22925–22928
   PubMed Web of Science ®Google Scholar
• De Jong R., ten Hoeve J., Heisterkamp N., Groffen J. Crkl is complexed with tyrosine phosphorylated Cbl in Ph-positive leukemia. J Biol Chem 1995; 270: 21468–21471
   PubMed Web of Science ®Google Scholar
• Renshaw M. W., McWhirter J. R., Wang J. Y. J. The human leukemia oncogene bcr/abl abrogates the anchorage requirement but not the growth factor requirement for proliferation. Mol Cell Biol 1995; 15: 1286–1293
   PubMed Web of Science ®Google Scholar
• Bhatia R., Verfaillie C. M. Inhibition of BCR-ABL expression by antisense oligonucleotides normalizes pi integrin mediated adhesion and regulation of proliferation in chronic myelogenous leukemia. Blood 1995; 10(suppl. 1)1740A
   Google Scholar
• Bhatia R., Verfaillie C. Inhibition of BCR-ABL kinase activity with tyrphostin AG957 restores pi integrin mediated microenvironmental regulation of hematopoietic progenitor proliferation in CML. Blood 1996; 88(10)675A, suppl. 1
   Google Scholar
• Darnell J. E., Jr., Kerr I. M., Stark G. R. Jak-STAT pathways and transcriptional activation in response to interferons and other extracellular signaling proteins. Science 1994; 264: 1415–1421
   PubMed Web of Science ®Google Scholar
• Keating A., Wang X.-H., Laraya P. α-Interferon suppresses transcription of bcr-abl in Ph+ chronic myelogenous leukemia progenitor cells. Exp Hemat 1993; 21: 231A, (Abstr.)
   PubMedGoogle Scholar
• David M., Romero G., Zhang Z. Y., Dixon J. E., Larner A. C. In vitro activation of the transcription factor ISGF3 by interferon alpha involves a membrane associated tyrosine phosphatase and tyrosine kinase. J Biol Chem. 1993; 268: 6593–6599
   PubMed Web of Science ®Google Scholar
• Tauchi T., Feng G.-S., Shen R., Song H. Y., Donner D., Pawson T., Broxmeyer H. E. SH2-containing Phosphotyrosine Phosphatase Syp Is a Target of p210bcr-abl Tyrosine Kinase. J Biol Chem 1994; 269(21)15381–15387
   PubMed Web of Science ®Google Scholar
• Pfeffer L. M., Landsberger F. R. Interferon-alpha modulates the plasma membrane-cytoskeletal complex of human lymphoblastoid cells sensitive to the antiproliferative action of interferon-alpha. J Interferon Res 1990; 10: 91–747
   PubMedGoogle Scholar
• Pfeffer L. M., Eisenkraft A. B. L., Reich N. C., Improta T., Baxter G., Daniel-Lssakani S., Strulovici B. Transmembrane signaling by interferon alpha involves diacyl-glycerol production and activation of the epsilon isoform of protein kinase C in Daudi cells. Proc Natl Acad Sci USA 1991; 88(18)7988–7992
   PubMed Web of Science ®Google Scholar
• Evans S. S., Collea R. P., Appenheimer M. M., Golnick S. O. Interferon-α induces the expression of L-Selectin homing receptors in human B lymphoid cells. J Cell Biol 1993; 123: 1889–1898
   PubMed Web of Science ®Google Scholar